CTLA4 and melanoma: Treatment options are: chemotherapy with dacarbazine, monoclonal antibody anti- cytotoxic T-lymphocytes-associates antigen 4 (CTLA-4) ipililumab and vemurafenib for melanomas carrying BRAF V600E mutation [66,67,68,69].